Preliminary safety, pharmacokinetics, and efficacy of ERAS-0015: Results from the AURORAS-1 first-in-human trial
European Journal of Cancer · 2026-11 · 248 · 117458
DOI: 10.1016/j.ejca.2026.117458 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von J. Wang und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, J., Spira, A., Murciano-Goroff, Y., Massarelli, E., Garrido-Laguna, I., Singh, H., Lew, E., Metcalf, C., Lam, J., Lee, G., Xing, D., Brail, L., Morris, S., & Hong, D. (2026). Preliminary safety, pharmacokinetics, and efficacy of ERAS-0015: Results from the AURORAS-1 first-in-human trial. European Journal of Cancer, 248, 117458. https://doi.org/10.1016/j.ejca.2026.117458
Vancouver
Wang J, Spira A, Murciano-Goroff Y, Massarelli E, Garrido-Laguna I, Singh H, et al. Preliminary safety, pharmacokinetics, and efficacy of ERAS-0015: Results from the AURORAS-1 first-in-human trial. European Journal of Cancer. 2026;248:117458. doi:10.1016/j.ejca.2026.117458
BibTeX
@article{Wang2026,
author = {Wang, J. and Spira, A. and Murciano-Goroff, Y. and Massarelli, E. and Garrido-Laguna, I. and Singh, H. and Lew, E. and Metcalf, C. and Lam, J. and Lee, G. and Xing, D. and Brail, L. and Morris, S. and Hong, D.},
title = {Preliminary safety, pharmacokinetics, and efficacy of ERAS-0015: Results from the AURORAS-1 first-in-human trial},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117458},
doi = {10.1016/j.ejca.2026.117458}
}
EUVIMED